Publications by authors named "Eberhart C"

Background: Atypical teratoid rhabdoid tumor (ATRT) is the most common malignant brain tumor in infants, and more than 60% of children with ATRT die from their tumor. ATRT is associated with mutational inactivation/deletion of , a member of the SWI/SNF chromatin remodeling complex, suggesting that epigenetic events play a critical role in tumor development and progression. Moreover, disruption of SWI/SNF allows unopposed activity of epigenetic repressors, which contribute to tumorigenicity.

View Article and Find Full Text PDF
Article Synopsis
  • Brain surgeons need standardized rules for handling brain tumors during surgery to improve diagnosis and treatment.*
  • Right now, guidelines mainly exist for one type of brain tumor, but others could also benefit from these rules.*
  • Having experts from different fields work together is important for creating these standardized practices to help patients and research better.*
View Article and Find Full Text PDF

Introduction: This is a prospective, rigorous inquiry into the systemic immune effects of standard adjuvant chemoradiotherapy, for WHO grade 4, glioblastoma. The purpose is to identify peripheral immunologic effects never yet reported in key immune populations, including myeloid-derived suppressor cells, which are critical to the immune suppressive environment of glioblastoma. We hypothesize that harmful immune-supportive white blood cells, myeloid derived suppressor cells, expand in response to conventionally fractionated radiotherapy with concurrent temozolomide, essentially promoting systemic immunity similar what is seen in chronic diseases like diabetes and heart disease.

View Article and Find Full Text PDF
Article Synopsis
  • Ocular adnexal sebaceous carcinoma (SebCA) is a type of eye tumor that is hard to understand and often needs intense surgery to treat.
  • Researchers aimed to create new cell lines from tumor samples to better study the tumor and test drugs.
  • Three cell lines were created, showing specific growth patterns and reactions to drug treatments, which will help scientists learn more about SebCA and find better treatment options.
View Article and Find Full Text PDF
Article Synopsis
  • * The study identifies a five-gene signature linked to N6-methyladenosine (m6A) RNA modification that is associated with patient survival and can improve risk assessment in medulloblastoma through a machine learning classification model.
  • * Findings indicate that m6A-associated long non-coding RNAs influence tumor progression and immune responses, suggesting potential new targets for treatment and the development of clinical tools for better management of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed 469 tumor samples to discover a five-gene m6A-associated long non-coding RNA (lncRNA) signature (M6LSig) that correlates with overall survival and developed a clinical nomogram to predict patient prognosis.
  • * The study found that the expression of m6A-associated lncRNAs is linked to immune cell types in the tumor environment and demonstrated that silencing key m6A genes slows tumor growth, underscoring the potential of
View Article and Find Full Text PDF

We introduce a two-pronged strategy comprising focused ultrasound (FUS)-mediated blood-brain barrier (BBB) opening and long-circulating biodegradable nanoparticles (NPs) for systemic delivery of nucleic acids to the brain. Biodegradable poly(β-amino ester) polymer-based NPs were engineered to stably package various types of nucleic acid payloads and enable prolonged systemic circulation while retaining excellent serum stability. FUS was applied to a predetermined coordinate within the brain to transiently open the BBB, thereby allowing the systemically administered long-circulating NPs to traverse the BBB and accumulate in the FUS-treated brain region, where plasmid DNA or mRNA payloads produced reporter proteins in astrocytes and neurons.

View Article and Find Full Text PDF

Background: Relapsed medulloblastoma (MB) poses a significant therapeutic challenge due to its highly immunosuppressive tumor microenvironment. Immune checkpoint inhibitors (ICIs) have struggled to mitigate this challenge, largely due to low T-cell infiltration and minimal PD-L1 expression. Identifying the mechanisms driving low T-cell infiltration is crucial for developing more effective immunotherapies.

View Article and Find Full Text PDF

Li-Fraumeni syndrome (LFS) is caused by a pathogenic germline variant at the locus and is associated with an increased predisposition to a variety of cancers. The neoplasms most frequently associated with LFS are sarcomas, breast cancer, brain tumors, and adrenocortical carcinomas. In this case report, we present a 43-year-old male diagnosed with an ocular adnexal sebaceous carcinoma of the right upper eyelid who was confirmed to have LFS with subsequent genetic testing.

View Article and Find Full Text PDF
Article Synopsis
  • The blood-tumor barrier (BTB) in malignant glioma limits the effectiveness of cytotoxic drugs, and this study investigates how ibrutinib, a drug already approved for lymphoma, impacts BTB function.
  • Ibrutinib was found to dose-dependently reduce brain endothelial cell adhesion and disrupt tight junctions, enhancing penetration of the drug doxil into the tumor and significantly reducing glioma cell viability.
  • The combination of ibrutinib and doxil not only improved drug concentration in the brain but also extended the survival of rodent glioma models, highlighting ibrutinib’s potential to enhance therapeutic efficacy in glioma treatment.
View Article and Find Full Text PDF

Background: Diffuse intrinsic pontine glioma (DIPG) is a uniformly lethal brainstem tumor of childhood, driven by histone H3 K27M mutation and resultant epigenetic dysregulation. Epigenomic analyses of DIPG have shown global loss of repressive chromatin marks accompanied by DNA hypomethylation. However, studies providing a static view of the epigenome do not adequately capture the regulatory underpinnings of DIPG cellular heterogeneity and plasticity.

View Article and Find Full Text PDF

Recent studies suggest that long non-coding RNAs (lncRNAs) contribute to medulloblastoma (MB) formation and progression. We have identified an lncRNA, lnc-HLX-2-7, as a potential therapeutic target in group 3 (G3) MBs. lnc-HLX-2-7 RNA specifically accumulates in the promoter region of HLX, a sense-overlapping gene of lnc-HLX-2-7, which activates HLX expression by recruiting multiple factors, including enhancer elements.

View Article and Find Full Text PDF

Adult medulloblastomas (MB) are rare, and optimal post-craniospinal irradiation (CSI) chemotherapy is not yet defined. We investigated hematological toxicity in patients treated with platinum-etoposide (EP) post-CSI. Retrospective, single-institution study to determine hematological toxicity in adult MB patients treated with EP (1995-2022).

View Article and Find Full Text PDF

NF2-related schwannomatosis (NF2) is a rare autosomal-dominant genetic disorder characterized by bilateral vestibular schwannomas and multiple meningiomas. This case report presents the extremely rare occurrence of an anaplastic meningioma in a 12-year-old male with previously undiagnosed NF2. The patient presented with a history of abdominal pain and episodic emesis, gait unsteadiness, right upper and lower extremity weakness, and facial weakness.

View Article and Find Full Text PDF

Purpose: Proliferative vitreoretinopathy (PVR) is the most common cause of failure of surgically repaired rhegmatogenous retinal detachment (RRD). Chemically induced and cell injection PVR models do not fully simulate the clinical characteristics of PVR in the post-RRD context. There is an unmet need for translational models in which to study mechanisms and treatments specific to RRD-PVR.

View Article and Find Full Text PDF

The prognosis of childhood medulloblastoma (MB) is often poor, and it usually requires aggressive therapy that adversely affects quality of life. microRNA-211 (miR-211) was previously identified as an important regulator of cells that descend from neural cells. Since medulloblastomas primarily affect cells with similar ontogeny, we investigated the role and mechanism of miR-211 in MB.

View Article and Find Full Text PDF

It has previously been reported that antioxidant vitamins can help reduce the risk of vision loss associated with progression to advanced age-related macular degeneration (AMD), a leading cause of visual impairment among the elderly. Nonetheless, how oxidative stress contributes to the development of choroidal neovascularization (CNV) in some AMD patients and geographic atrophy (GA) in others is poorly understood. Here, we provide evidence demonstrating that oxidative stress cooperates with hypoxia to synergistically stimulate the accumulation of hypoxia-inducible factor (HIF)-1α in the retinal pigment epithelium (RPE), resulting in increased expression of the HIF-1-dependent angiogenic mediators that promote CNV.

View Article and Find Full Text PDF

We here introduce a novel bioreducible polymer-based gene delivery platform enabling widespread transgene expression in multiple brain regions with therapeutic relevance following intracranial convection-enhanced delivery. Our bioreducible nanoparticles provide markedly enhanced gene delivery efficacy and compared to nonbiodegradable nanoparticles primarily due to the ability to release gene payloads preferentially inside cells. Remarkably, our platform exhibits competitive gene delivery efficacy in a neuron-rich brain region compared to a viral vector under previous and current clinical investigations with demonstrated positive outcomes.

View Article and Find Full Text PDF

Mpox is an emerging zoonotic infection with potentially severe ocular and periocular consequences, particularly in immunocompromised patients. This report summarizes 2 cases of fulminant mpox presenting in patients with AIDS. In the first case, confluent lesions resulted in orbital compartment syndrome and total eyelid necrosis.

View Article and Find Full Text PDF